Complement-mediated Hemolytic Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Complement-mediated Hemolytic Diseases trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Complement-mediated Hemolytic Diseases trials you may qualify forThis protocol is part of a larger project, COMPRare (COMPlement-mediated Rare kidney diseases), which has been financed on behalf of the EJP RD (European Joint…
The study is being conducted to compare the drug-drug interaction of HRS-5965 with clopidogrel and clarithromycin in healthy subjects.
NTQ5082 capsule is a small molecule CFB factor inhibitor. The study is a randomized, double-blind, placebo-controlled, dose escalation phase 1 clinical trial to…